...
首页> 外文期刊>Internal medicine. >Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
【24h】

Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.

机译:在最初被诊断为患有2型糖尿病的患者中,谷氨酸脱羧酶抗体发生血清转化。

获取原文
获取原文并翻译 | 示例
           

摘要

A 61-year-old man admitted in July 1998 had suffered from thirst, polydipsia and polyuria for three years. Diet and transient insulin therapy had induced good blood glucose control which was maintained by metformin hydrochloride for a year. Although it worsened, conventional insulin treatment re-implemented good blood glucose control. Glutamic acid decarboxylase antibodies (GAD-Ab) had been negative up to this point. After 8 months, blood glucose levels became elevated. To date, the GAD-Ab has been positive (112-120 U/ml), and the serum and urine C-peptide levels are decreased. Seroconversion of GAD-Ab should be noted in patients initially diagnosed as having GAD-Ab negative type 2 diabetes mellitus.
机译:1998年7月入院的一名61岁男子患有口渴,多饮和多尿3年。饮食和短暂的胰岛素治疗已引起良好的血糖控制,而盐酸二甲双胍维持了一年。尽管情况恶化,但常规胰岛素治疗重新实现了良好的血糖控制。到目前为止,谷氨酸脱羧酶抗体(GAD-Ab)呈阴性。 8个月后,血糖水平升高。迄今为止,GAD-Ab呈阳性(112-120 U / ml),血清和尿液C肽水平降低。在最初诊断为GAD-Ab阴性2型糖尿病患者中应注意GAD-Ab的血清转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号